Caffeine inhibits the expression of SREBP2 at the transcriptional level by increasing the Ca2+ concentration in the hepatic ER, thereby reducing the expression of PCSK9 and the risk of cardiovascular disease (51). The gene discussed is PCSK9; the disease is cardiovascular disorder.